4//SEC Filing
Kalkofen Donald A. 4
Accession 0001209191-19-034082
CIK 0001377121other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 7:40 PM ET
Size
5.6 KB
Accession
0001209191-19-034082
Insider Transaction Report
Form 4
Kalkofen Donald A.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-05-31+100,000→ 100,000 totalExercise: $10.06Exp: 2029-05-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option vests over a four-year period with 25% of the shares underlying the option vesting on the one-year anniversary of the vesting commencement date of May 28, 2019, and the balance vesting in equal monthly installments over the following 36 months.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001771066
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 7:40 PM ET
- Size
- 5.6 KB